4
Changes in Ownership
UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000177
Chairperson & CEO sold 9,500 shares at an average $596.22 ($5,664,136)
- Chairperson & CEO acquired 9,500 shares (option exercise)
- Traded under a Rule 10b5-1 plan
From the SEC's structured data for this filing
Trades in this filing
ROTHBLATT MARTINE A · Chairperson & CEO
Table I: Non-derivative
8 lines| Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|
| 2026-11-02 | Exercise or conversion : show line 1 in the form 10b5-1 | +9,500 | $117.76 | $1,118,720 | 333,943 | I |
| 2026-11-02 | Sale : show line 2 in the form 10b5-1 | −223 | $593.09 | $132,259 | 333,720 | I |
| 2026-11-02 | Sale : show line 3 in the form 10b5-1 | −905 | $594.03 | $537,597 | 332,815 | I |
| 2026-11-02 | Sale : show line 4 in the form 10b5-1 | −1,599 | $595.15 | $951,644 | 331,216 | I |
| 2026-11-02 | Sale : show line 5 in the form 10b5-1 | −2,776 | $596.11 | $1,654,807 | 328,440 | I |
| 2026-11-02 | Sale : show line 6 in the form 10b5-1 | −2,517 | $597.02 | $1,502,690 | 325,923 | I |
| 2026-11-02 | Sale : show line 7 in the form 10b5-1 | −1,280 | $597.95 | $765,371 | 324,643 | I |
| 2026-11-02 | Sale : show line 8 in the form 10b5-1 | −200 | $598.84 | $119,768 | 324,443 | I |
| Open-market sales · 9,500 sh · avg $596.22 · $5,664,136 | ||||||
Table II: Derivative
1 line| Date | Transaction | Shares | Owned after | D/I |
|---|---|---|---|---|
| 2026-11-02 | Exercise or conversion : show line 9 in the form 10b5-1 Stock Option | −9,500 | 109,910 | I |
Loading xslF345X06/primarydocument.xml…